[1] |
CHEN Guo , HAN Pengli , CHEN Keru , LI Mingchuang , ZHANG Qingsong , CHEN Zheng , DONG Hanhua , QIAN Yuejun , LÜ Jing .
Molecular mechanism of miR-19b-3p regulating apoptosis of medullary thyroid cancer cells by targeting MTUS1
[J]. China Oncology, 2021, 31(5): 390-396.
|
[2] |
YUAN Hao , JIANG Xiaofei , YOU Qinghua , ZHU Hongbo , YE Huiying , WU Wen , QIAN Fengyuan , ZHONG Ming , LI Yongping .
Clinical application of fine needle puncture Diff-Quik staining for the differentiation and protection of parathyroid glands in thyroid carcinoma surgery
[J]. China Oncology, 2021, 31(4): 302-307.
|
[3] |
WU Yuanyuan , WANG Jun , LIU Qinjiang , ZHANG Ming .
Analysis of prognostic factors and treatment strategies of anaplastic thyroid carcinoma
[J]. China Oncology, 2021, 31(3): 212-220.
|
[4] |
WU Hongwen, MEI Yan, WANG Qiao, YUAN Jia, ZHAO Liwei.
The clinical value of serum MIP-1α and S-TK1 in the evaluation of postoperative radioactive 131 I treatment for thyroid carcinoma
[J]. China Oncology, 2021, 31(11): 1088-1095.
|
[5] |
LIU Jiawei, LI Dan, ZHAI Qing.
Risk factors analysis of liver injury induced by chemotherapy in patients with breast cancer
[J]. China Oncology, 2021, 31(1): 52-62.
|
[6] |
LI Min, WEN Peng, QIAN Qiuqin, QIN Ang, ZENG Li, SHI Feng.
Clinical study of iodine-125 seeds implantation in the treatment of lymph node metastasis of radioactive iodine- refractory differentiated thyroid cancer
[J]. China Oncology, 2020, 30(2): 122-127.
|
[7] |
MU Zhuanzhuan , LI Zheng , ZHANG Xin , LIN Yansong .
The effect of empiric 131 I therapy in papillary thyroid cancer patients with pulmonary metastasis
[J]. China Oncology, 2020, 30(12): 991-995.
|
[8] |
DING Pingan, YANG Peigang, TIAN Yuan, GUO Ziyang, GUO Honghai, LIU Yang, ZHANG Zhidong, WANG Dong, LI Yong, ZHAO Qun.
Effect of extranodal invasion on survival and prognosis of gastric cancer patients: a report of 2 386 cases
[J]. China Oncology, 2020, 30(12): 1017-1025.
|
[9] |
REN Junling , CHEN Bin , TANG Xiaolei .
Research on the correlation between BMI and pathologic factors of papillary thyroid carcinoma
[J]. China Oncology, 2020, 30(12): 1041-1045.
|
[10] |
LU Linjun , XU Xiaoping , XU Junyan , ZHANG Jiangang , ZHANG Yingjian , SONG Shaoli , ZHANG Jianping .
A study on the dose of 99m Tc-HYNIC-TOC in humans
[J]. China Oncology, 2020, 30(11): 872-878.
|
[11] |
MA Xiaokai,HUANG Jiankang,ZHU Bo,PENG Defeng,ZHOU Rui,WANG Shengying .
Clinical characteristics of papillary thyroid microcarcinoma and risk factors for cervical lymph node metastasis: a clinical analysis of 228 cases
[J]. China Oncology, 2019, 29(8): 590-594.
|
[12] |
MIAO Changfeng,MA Yuntao,WANG Xiaopeng,HU Ming,YANG Xiaojun .
Construction of the risk factor model of gastric cancer and its value in screening opportunity and options
[J]. China Oncology, 2019, 29(7): 501-507.
|
[13] |
YANG Ke, ZHENG Rong, LIN Yansong.
The interpretation of management guidelines for children with thyroid nodules and differentiated thyroid cancer: radioactive iodine therapy and new progress
[J]. China Oncology, 2019, 29(6): 401-411.
|
[14] |
ZHANG Liyang, LIU Chunhao, CAO Yue, LIU Hongfeng, GAO Weisheng, LI Xiaoyi.
Experiences of 125 cases of re-operated persistent/recurrent differentiated thyroid cancer
[J]. China Oncology, 2019, 29(6): 412-417.
|
[15] |
GAO Luying, LIN Yansong, JIANG Yuxin, LI Jianchu, LI Hui, ZHANG Bo, LIU Ruyu, XI Xuehua, GAO Qiong, WANG Ying, ZHAO Ruina.
Evaluation of short-term efficacy of apatinib using cervical ultrasound and thyroglobulin in the treatment of progressive radioactive iodine-refractory differentiated thyroid cancer
[J]. China Oncology, 2019, 29(6): 418-422.
|